Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jorne Lionel Biccler"'
Autor:
Michael Asger Andersen, Casper Tabassum Eriksen, Christian Brieghel, Jorne Lionel Biccler, Caspar da Cunha-Bang, Marie Helleberg, Carsten Utoft Niemann
Publikováno v:
Haematologica, Vol 103, Iss 7 (2018)
Externí odkaz:
https://doaj.org/article/0464578a8428411c9673794fcc615127
Autor:
Caroline Holm Nørgaard, Nikoline Buus Søgaard, Jorne Lionel Biccler, Laura Pilgaard, Mathias Holmsgaard Eskesen, Thordis Helga Kjartansdottir, Martin Bøgsted, Tarec Christoffer El-Galaly
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208180 (2018)
IntroductionThe majority of newly diagnosed chronic lymphocytic leukemia (CLL) patients are followed initially by watch and wait (WAW). Clinical practice varies and the value of frequent follow-up visits remains unclear. Thus, in this study we invest
Externí odkaz:
https://doaj.org/article/4149c58c86744a6ab59f042e81cc4f67
Autor:
Judit Jørgensen, Martin Bøgsted, Michael Roost Clausen, Jorne Lionel Biccler, Marianne Tang Severinsen, Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen, Jørn Starklint, Maja Bech Juul, Christian Bjørn Poulsen, Peter de Nully Brown, Pär Josefsson, Per Trøllund Pedersen
Publikováno v:
Jakobsen, L H, Biccler, J L, Brown, P D N, Jørgensen, J M, Josefsson, P L, Poulsen, C B, Starklint, J, Clausen, M R, Pedersen, P T, Juul, M B, Severinsen, M T, Bøgsted, M & El-Galaly, T C 2019, ' No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma : a Danish population-based study of 3783 patients ', Leukemia and Lymphoma, vol. 60, no. 11, pp. 2798-2801 . https://doi.org/10.1080/10428194.2019.1602264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddedd7a32706c92ea43b0138ebbf7a96
https://doi.org/10.1080/10428194.2019.1602264
https://doi.org/10.1080/10428194.2019.1602264
Supplemental material, SMM910193 Supplemental Material for Outlier robust modeling of survival curves in the presence of potentially time-varying coefficients by Jorne Lionel Biccler, Martin Bøgsted, Stefan Van Aelst and Tim Verdonck in Statistical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f4fc53f57d362d66993977ab4bec7e
Autor:
Tarec Christoffer El-Galaly, Jacob Haaber Christensen, Pär Josefsson, Lasse Hjort Jakobsen, Jorne Lionel Biccler, Andriette Dessau, Christian Bjørn Poulsen, Judit Jørgensen, Maja Bech Juul, Jørn Starklint, Peter de Nully Brown, Martin Bøgsted
Publikováno v:
Biccler, J L, El-Galaly, T C, Bøgsted, M, Jørgensen, J, de Nully Brown, P, Poulsen, C B, Starklint, J, Juul, M B, Christensen, J H, Josefsson, P, Dessau, A & Jakobsen, L H 2019, ' Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas ', Leukemia and Lymphoma, vol. 60, no. 6, pp. 1580–1583 . https://doi.org/10.1080/10428194.2018.1540044
Biccler, J L, El-Galaly, T C, Bøgsted, M, Jørgensen, J, de Nully Brown, P, Poulsen, C B, Starklint, J, Juul, M B, Christensen, J H, Josefsson, P, Dessau, A & Jakobsen, L H 2019, ' Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas ', Leukemia and Lymphoma, vol. 60, no. 6, pp. 1580-1583 . https://doi.org/10.1080/10428194.2018.1540044
Biccler, J L, El-Galaly, T C, Bøgsted, M, Jørgensen, J, de Nully Brown, P, Poulsen, C B, Starklint, J, Juul, M B, Christensen, J H, Josefsson, P, Dessau, A & Jakobsen, L H 2019, ' Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas ', Leukemia and Lymphoma, vol. 60, no. 6, pp. 1580-1583 . https://doi.org/10.1080/10428194.2018.1540044
Malignant lymphomas comprise a heterogeneous group of diseases with important differences in pathogenesis, management strategies, and outcome [1]. To obtain information about prognosis in daily pra...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0d6c197abe24e803ff91a3c6324e2b
https://doi.org/10.1080/10428194.2018.1540044
https://doi.org/10.1080/10428194.2018.1540044
Autor:
Therese M.-L. Andersson, Lasse Hjort Jakobsen, Laurids Østergaard Poulsen, Martin Bøgsted, Jorne Lionel Biccler, Tarec Christoffer El-Galaly, Marianne Tang Severinsen
Publikováno v:
BMC Medical Research Methodology
Jakobsen, L H, Andersson, T M-L, Biccler, J L, Poulsen, L Ø, Severinsen, M T, El-Galaly, T C & Bøgsted, M 2020, ' On estimating the time to statistical cure ', BMC Medical Research Methodology, vol. 20, no. 1, 71 . https://doi.org/10.1186/s12874-020-00946-8
BMC Medical Research Methodology, Vol 20, Iss 1, Pp 1-13 (2020)
Jakobsen, L H, Andersson, T M-L, Biccler, J L, Poulsen, L Ø, Severinsen, M T, El-Galaly, T C & Bøgsted, M 2020, ' On estimating the time to statistical cure ', BMC Medical Research Methodology, vol. 20, no. 1, 71 . https://doi.org/10.1186/s12874-020-00946-8
BMC Medical Research Methodology, Vol 20, Iss 1, Pp 1-13 (2020)
Background The mortality risk among cancer patients measured from the time of diagnosis is often elevated in comparison to the general population. However, for some cancer types, the patient mortality risk will over time reach the same level as the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463b4bd2e88f8a2252c8d6965566e2f4
https://pubmed.ncbi.nlm.nih.gov/32216765
https://pubmed.ncbi.nlm.nih.gov/32216765
Autor:
Diego Villa, Laurie H. Sehn, Alina S. Gerrie, Kerry J. Savage, Jorne Lionel Biccler, Judit Jørgensen, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen, Martin Bøgsted, Danny Stoltenberg, Lasse Hjort Jakobsen, Christian Bjørn Poulsen, David W. Scott, Peter de Nully Brown
Publikováno v:
Biccler, J L, Savage, K J, Brown, P D N, Jørgensen, J, Larsen, T S, Poulsen, C B, Stoltenberg, D, Sehn, L H, Scott, D W, Gerrie, A S, Jakobsen, L H, Bøgsted, M, El-Galaly, T C & Villa, D 2019, ' Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma ', Leukemia and Lymphoma, vol. 60, no. 10, pp. 2516-2523 . https://doi.org/10.1080/10428194.2019.1594219
Biccler, J L, Savage, K J, de Nully Brown, P, Jørgensen, J, Larsen, T S, Poulsen, C B, Stoltenberg, D, Sehn, L H, Scott, D W, Gerrie, A S, Jakobsen, L H, Bøgsted, M, El-Galaly, T C & Villa, D 2019, ' Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma ', Leukemia and Lymphoma, vol. 60, no. 10, pp. 2516-2523 . https://doi.org/10.1080/10428194.2019.1594219
Biccler, J L, Savage, K J, de Nully Brown, P, Jørgensen, J, Larsen, T S, Poulsen, C B, Stoltenberg, D, Sehn, L H, Scott, D W, Gerrie, A S, Jakobsen, L H, Bøgsted, M, El-Galaly, T C & Villa, D 2019, ' Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma ', Leukemia and Lymphoma, vol. 60, no. 10, pp. 2516-2523 . https://doi.org/10.1080/10428194.2019.1594219
In this study, we analyzed the evolution of the prognosis of primary central nervous system lymphoma (PCNSL) patients as they reach selected progression-free survival (PFS) milestones after high-dose methotrexate (HD-MTX)-based therapy. In total, 258
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3663062e0aa95ae01ce838e75f5901db
https://pubmed.ncbi.nlm.nih.gov/30943052
https://pubmed.ncbi.nlm.nih.gov/30943052
Autor:
Sandra Eloranta, Karin E. Smedby, Therese M.-L. Andersson, Ingrid Glimelius, Henrik Frederiksen, Jorne Lionel Biccler, Tarec Christoffer El-Galaly, Peter de Nully Brown, Alexander Fosså, Mats Jerkeman, Martin Bøgsted, Lasse Hjort Jakobsen, Knut B. Smeland, Harald Holte
Publikováno v:
Biccler, J L, Glimelius, I, Eloranta, S, Smeland, K B, Brown, P D N, Jakobsen, L H, Frederiksen, H, Jerkeman, M, Fosså, A, Andersson, T M L, Holte, H, Bøgsted, M, El-Galaly, T C & Smedby, K E 2019, ' Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma : A Nordic Lymphoma Epidemiology Group Study ', Journal of Clinical Oncology, vol. 37, no. 9, pp. 703-713 . https://doi.org/10.1200/JCO.18.01652
PURPOSE Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma (cHL) are of considerable interest. We investigated cHL prognosis in the era of contemporary treatment at different milestones during the follow-up. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31aaf096db8c5202c864ae25a0173d7d
https://findresearcher.sdu.dk:8443/ws/files/159305964/jco.18.01652.pdf
https://findresearcher.sdu.dk:8443/ws/files/159305964/jco.18.01652.pdf
Autor:
Vishakha Sovani, Musa Alzahrani, Allison Barraclough, Clare Gould, Mark Bishton, Bradley Augustson, Tarec Christoffer El-Galaly, Pedro Farinha, Kerry J. Savage, David Scott, Maher K. Gandhi, Jorne Lionel Biccler, Simone Birch, Joseph M. Connors, Mitchell Steven Ward, Chan Yoon Cheah, Laurie H. Sehn, Marianne Schmidt Ettrup, Diego Villa, Chris Van Vliet
Publikováno v:
Barraclough, A, Alzahrani, M, Ettrup, M S, Bishton, M, van Vliet, C, Farinha, P, Gould, C, Birch, S, Sehn, L H, Sovani, V, Ward, M S, Augustson, B, Biccler, J, Connors, J M, Scott, D W, Gandhi, M K, Savage, K J, El-Galaly, T, Villa, D & Cheah, C Y 2019, ' COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL : a retrospective multicenter study ', Blood advances, vol. 3, no. 13, pp. 2013-2021 . https://doi.org/10.1182/bloodadvances.2019000251
In advanced-stage diffuse large B-cell lymphoma (DLBCL), the presence of an activated B-cell phenotype or a non–germinal center (GCB) phenotype, coexpression of MYC and BCL2 by immunohistochemistry, and the cooccurrence of MYC and BCL2 or BCL6 rear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a81a9b3f2d0cdc678efad1af21b3840c
https://pubmed.ncbi.nlm.nih.gov/31285189
https://pubmed.ncbi.nlm.nih.gov/31285189
Autor:
Dejan Radeski, Tarec Christoffer El-Galaly, David Joske, Greg Hapgood, Heshani Mediwake, Jorne Lionel Biccler, Collin K. Chin, Chan Yoon Cheah, Gavin Cull, Diego Villa, E. Tsang, W. Khair, Z. Nizich, Peter Mollee
Publikováno v:
Chin, C K, Tsang, E, Mediwake, H, Khair, W, Biccler, J, Hapgood, G, Mollee, P, Nizich, Z, Joske, D, Radeski, D, Cull, G, Villa, D, El-Galaly, T C & Cheah, C Y 2019, ' Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement ', British Journal of Haematology, vol. 184, no. 5, pp. 826-828 . https://doi.org/10.1111/bjh.15173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c69b0e2e77ec4d859db976af0bdb17
https://vbn.aau.dk/da/publications/498a1a21-2298-42c9-a50a-36c82a7910c5
https://vbn.aau.dk/da/publications/498a1a21-2298-42c9-a50a-36c82a7910c5